Corteva (CTVA)
Market Price (7/23/2026): $88.85 | Market Cap: $59.8 BilSector: Materials | Industry: Fertilizers & Agricultural Chemicals
Corteva (CTVA)
Market Price (7/23/2026): $88.85Market Cap: $59.8 BilSector: MaterialsIndustry: Fertilizers & Agricultural Chemicals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 11%, CFO LTM is 2.6 Bil, FCF LTM is 2.0 Bil Stock buyback supportStock Buyback 3Y Total is 2.6 Bil Low stock price volatilityVol 12M is 24% Megatrend and thematic driversMegatrends include Biotechnology & Genomics, Advanced Materials, and Sustainable Resource Management. Themes include Gene Editing & Therapy, Show more. | Trading close to highsDist 52W High is 0.0%, Dist 3Y High is 0.0% | Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 31x, P/EPrice/Earnings or Price/(Net Income) is 51x Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.4% Key risksCTVA key risks include [1] unpredictable regulatory approvals for its specific biotechnology and crop protection pipeline, Show more. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 11%, CFO LTM is 2.6 Bil, FCF LTM is 2.0 Bil |
| Stock buyback supportStock Buyback 3Y Total is 2.6 Bil |
| Low stock price volatilityVol 12M is 24% |
| Megatrend and thematic driversMegatrends include Biotechnology & Genomics, Advanced Materials, and Sustainable Resource Management. Themes include Gene Editing & Therapy, Show more. |
| Trading close to highsDist 52W High is 0.0%, Dist 3Y High is 0.0% |
| Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 31x, P/EPrice/Earnings or Price/(Net Income) is 51x |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.4% |
| Key risksCTVA key risks include [1] unpredictable regulatory approvals for its specific biotechnology and crop protection pipeline, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Corteva (CTVA) stock has gained about 5% since 3/31/2026 because of the following key factors:
1. Strong Fiscal Q1 2026 Earnings Beat and Reaffirmed Full-Year Guidance.
Corteva reported robust fiscal Q1 2026 results on May 5, 2026, with net sales increasing 11% year-over-year to $4.90 billion, exceeding analyst estimates of $4.64 billion. Operating EPS reached $1.50, significantly surpassing the consensus estimate of $1.18 by $0.32. The company further bolstered investor confidence by reaffirming its full-year fiscal 2026 guidance, projecting Operating EBITDA of $4.0 billion to $4.2 billion and Operating EPS of $3.45 to $3.70 per share, both representing approximately 7% growth at the midpoint.
2. Continued Progress Towards Strategic Separation into Two Independent Companies.
Corteva made substantial advancements in its plan to separate into two independent, publicly traded companies by fiscal Q4 2026: "New Corteva" (focused on crop protection) and "Vylor" (focused on advanced seed and genetics). In June 2026, the company announced the initial boards of directors for both the future Crop Protection company and the Advanced Seed and Genetics spin-off, Vylor, alongside specifying their distinct headquarters. These concrete steps signal progress towards a strategic move widely anticipated to unlock additional shareholder value.
Show more
Corteva (CTVA) stock has gained about 5% since 3/31/2026 because of the following key factors:
1. Strong Fiscal Q1 2026 Earnings Beat and Reaffirmed Full-Year Guidance.
Corteva reported robust fiscal Q1 2026 results on May 5, 2026, with net sales increasing 11% year-over-year to $4.90 billion, exceeding analyst estimates of $4.64 billion. Operating EPS reached $1.50, significantly surpassing the consensus estimate of $1.18 by $0.32. The company further bolstered investor confidence by reaffirming its full-year fiscal 2026 guidance, projecting Operating EBITDA of $4.0 billion to $4.2 billion and Operating EPS of $3.45 to $3.70 per share, both representing approximately 7% growth at the midpoint.
2. Continued Progress Towards Strategic Separation into Two Independent Companies.
Corteva made substantial advancements in its plan to separate into two independent, publicly traded companies by fiscal Q4 2026: "New Corteva" (focused on crop protection) and "Vylor" (focused on advanced seed and genetics). In June 2026, the company announced the initial boards of directors for both the future Crop Protection company and the Advanced Seed and Genetics spin-off, Vylor, alongside specifying their distinct headquarters. These concrete steps signal progress towards a strategic move widely anticipated to unlock additional shareholder value.
3. Favorable Analyst Sentiment and Multiple Price Target Upgrades.
Analysts maintained a predominantly bullish outlook on Corteva, with a consensus rating ranging from "Moderate Buy" to "Buy" from various firms. Several financial institutions raised their price targets for CTVA during this period. For instance, Argus Research increased its price target from $80 to $91 on March 31, 2026, while Wells Fargo & Company raised its target from $85.00 to $90.00 on April 21, 2026. Royal Bank of Canada also boosted its objective from $95.00 to $97.00 on May 7, 2026, and Mizuho set a price target of $97.00 on July 14, 2026, implying an approximate 11.94% upside from recent levels. The average analyst price target for Corteva during this period indicated a potential further upside for the stock.
4. Robust Product Innovation and Portfolio Expansion.
Corteva demonstrated a strong commitment to innovation through the launch of new products and enhancements to its existing portfolio, particularly in crop protection and seed treatments. Early in fiscal 2026, the company introduced three new herbicides: Kyber Pro, Sonic Boom, and Enversa. In June 2026, Corteva announced the upcoming launch of Forcivo fungicide, designed to offer broad-spectrum disease control with extended residual activity of up to 30 days. Additionally, the company enhanced its LumiGEN corn seed treatment package with a new biological plant nutrition component, Lumidapt Valta LS, aimed at promoting superior germination and root development. These new offerings reinforce Corteva's differentiated product strategy and its ability to meet evolving farmer needs.
Show less
Stock Movement Drivers
Fundamental Drivers
The 6.0% change in CTVA stock from 3/31/2026 to 7/22/2026 was primarily driven by a 3.3% change in the company's Net Income Margin (%).| (LTM values as of) | 3312026 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 83.52 | 88.53 | 6.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 17,401 | 17,889 | 2.8% |
| Net Income Margin (%) | 6.3% | 6.5% | 3.3% |
| P/E Multiple | 51.5 | 51.2 | -0.6% |
| Shares Outstanding (Mil) | 675 | 672 | 0.4% |
| Cumulative Contribution | 6.0% |
Market Drivers
3/31/2026 to 7/22/2026| Return | Correlation | |
|---|---|---|
| CTVA | 6.0% | |
| Market (SPY) | 14.9% | -3.1% |
| Sector (XLB) | 1.7% | 34.8% |
Fundamental Drivers
The 32.7% change in CTVA stock from 12/31/2025 to 7/22/2026 was primarily driven by a 81.6% change in the company's P/E Multiple.| (LTM values as of) | 12312025 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 66.73 | 88.53 | 32.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 17,469 | 17,889 | 2.4% |
| Net Income Margin (%) | 9.2% | 6.5% | -29.3% |
| P/E Multiple | 28.2 | 51.2 | 81.6% |
| Shares Outstanding (Mil) | 679 | 672 | 0.9% |
| Cumulative Contribution | 32.7% |
Market Drivers
12/31/2025 to 7/22/2026| Return | Correlation | |
|---|---|---|
| CTVA | 32.7% | |
| Market (SPY) | 9.9% | 9.6% |
| Sector (XLB) | 12.6% | 49.1% |
Fundamental Drivers
The 19.9% change in CTVA stock from 6/30/2025 to 7/22/2026 was primarily driven by a 15.2% change in the company's P/E Multiple.| (LTM values as of) | 6302025 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 73.81 | 88.53 | 19.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 16,833 | 17,889 | 6.3% |
| Net Income Margin (%) | 6.8% | 6.5% | -4.1% |
| P/E Multiple | 44.5 | 51.2 | 15.2% |
| Shares Outstanding (Mil) | 687 | 672 | 2.1% |
| Cumulative Contribution | 19.9% |
Market Drivers
6/30/2025 to 7/22/2026| Return | Correlation | |
|---|---|---|
| CTVA | 19.9% | |
| Market (SPY) | 22.0% | 12.0% |
| Sector (XLB) | 17.4% | 47.1% |
Fundamental Drivers
The 59.7% change in CTVA stock from 6/30/2023 to 7/22/2026 was primarily driven by a 52.7% change in the company's P/E Multiple.| (LTM values as of) | 6302023 | 7222026 | Change |
|---|---|---|---|
| Stock Price ($) | 55.44 | 88.53 | 59.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 17,738 | 17,889 | 0.9% |
| Net Income Margin (%) | 6.6% | 6.5% | -2.2% |
| P/E Multiple | 33.6 | 51.2 | 52.7% |
| Shares Outstanding (Mil) | 713 | 672 | 6.0% |
| Cumulative Contribution | 59.7% |
Market Drivers
6/30/2023 to 7/22/2026| Return | Correlation | |
|---|---|---|
| CTVA | 59.7% | |
| Market (SPY) | 74.6% | 33.4% |
| Sector (XLB) | 29.4% | 52.8% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CTVA Return | 24% | 26% | -18% | 20% | 19% | 30% | 139% |
| Peers Return | 45% | 17% | -28% | -23% | -10% | 3% | -13% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 10% | 100% |
Monthly Win Rates [3] | |||||||
| CTVA Win Rate | 67% | 75% | 42% | 67% | 50% | 71% | |
| Peers Win Rate | 60% | 52% | 43% | 40% | 48% | 51% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 57% | |
Max Drawdowns [4] | |||||||
| CTVA Max Drawdown | -18% | -19% | -32% | -12% | -21% | -13% | |
| Peers Max Drawdown | -24% | -33% | -48% | -34% | -41% | -38% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: FMC, NTR, CF, MOS, AVD.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/22/2026 (YTD)
How Low Can It Go
| Event | CTVA | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -12.5% | -18.8% |
| % Gain to Breakeven | 14.3% | 23.1% |
| Time to Breakeven | 30 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -22.3% | -9.5% |
| % Gain to Breakeven | 28.7% | 10.5% |
| Time to Breakeven | 131 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -13.9% | -6.7% |
| % Gain to Breakeven | 16.2% | 7.1% |
| Time to Breakeven | 518 days | 31 days |
| 2020 COVID-19 Crash | ||
| % Loss | -33.9% | -33.7% |
| % Gain to Breakeven | 51.3% | 50.9% |
| Time to Breakeven | 206 days | 140 days |
In The Past
Corteva's stock fell -12.5% during the 2025 US Tariff Shock. Such a loss loss requires a 14.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | CTVA | S&P 500 |
|---|---|---|
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -22.3% | -9.5% |
| % Gain to Breakeven | 28.7% | 10.5% |
| Time to Breakeven | 131 days | 24 days |
| 2020 COVID-19 Crash | ||
| % Loss | -33.9% | -33.7% |
| % Gain to Breakeven | 51.3% | 50.9% |
| Time to Breakeven | 206 days | 140 days |
In The Past
Corteva's stock fell -12.5% during the 2025 US Tariff Shock. Such a loss loss requires a 14.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Corteva (CTVA)
Corteva, Inc. (CTVA) is a global agriculture company dedicated to providing farmers with solutions to enhance crop yield and protect their harvests. It operates through two primary segments: Seed and Crop Protection, offering a comprehensive suite of products and services designed to optimize agricultural productivity and profitability worldwide.
In its Seed segment, Corteva develops and supplies advanced germplasm and trait technologies. These innovations are engineered to produce optimal yields and provide crops with enhanced resistance to various challenges, including adverse weather, diseases, insects, and weeds, through specialized herbicides. This segment also offers digital solutions that empower farmers with data-driven insights to make informed decisions, ensuring optimal product selection and maximizing both yield and financial returns.
The Crop Protection segment focuses on safeguarding crops against a wide array of threats. Corteva provides essential products such as herbicides to control weeds, insecticides to combat pests, and fungicides to prevent diseases. Additionally, this segment offers nitrogen stabilizers and seed-applied technologies that improve overall crop health and nutrient management. Serving the agricultural input industry, Corteva's products reach farmers across North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
AI Analysis | Feedback
Corteva is like the Pfizer or Merck for plants, developing specialized seeds (akin to advanced genetic therapies) and crop protection products (like plant medicines and vaccines) to ensure healthy, high-yield harvests.
Think of Corteva as the 'Intel for agriculture', providing both the advanced genetic 'hardware' (seeds) and essential 'software' (crop protection products, digital tools) that farmers need to maximize their yields.
AI Analysis | Feedback
- Seeds: Corteva develops and supplies advanced germplasm and traits that produce optimum yield for farms, including technologies enhancing resistance to various challenges.
- Digital Agricultural Solutions: These are digital tools and platforms designed to assist farmers in decision-making to optimize product selection, yield, and profitability.
- Herbicides: Products used to control weeds, including those for general crop protection and specialized pasture and range management.
- Insecticides: Products formulated to protect crops from insects and other pests.
- Nitrogen Stabilizers: Products that manage nitrogen in the soil to enhance crop health and nutrient efficiency.
- Seed-Applied Technologies: Products applied directly to seeds to enhance crop health and provide early protection.
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
Chuck Magro - Chief Executive Officer
Chuck Magro was appointed Chief Executive Officer of Corteva in November 2021. Prior to joining Corteva, he served as President and CEO of Nutrien from the company's launch in 2018 until April 2021. Before Nutrien, he spent four years as President and CEO of Agrium, which merged with PotashCorp to form Nutrien. During his tenure at Nutrien, Mr. Magro led numerous mergers and acquisitions, expanding the company globally and restructuring the industry. He held various leadership positions at Agrium, including Chief Operating Officer, Chief Risk Officer, Executive Vice President of Corporate Development, and Vice President of Manufacturing. He joined Agrium in 2009 after a career with NOVA Chemicals.
David Johnson - Executive Vice President, Chief Financial Officer
David Johnson was appointed Executive Vice President and Chief Financial Officer of Corteva, effective September 16, 2024. He joined Corteva from Atkore, a publicly traded company specializing in electrical, safety, and infrastructure solutions, where he also served as CFO. During his six years at Atkore, he was responsible for all financial and information technology activities and oversaw the company's transformation through acquisitions and organic growth. Before Atkore, Mr. Johnson spent 29 years at Eaton Corporation, a power management company, holding various finance leadership roles, including Vice President, Finance and Operations for its Electrical Sector business. He has over three decades of experience in strategic and financial planning, risk assessment, mergers and acquisitions, global tax strategies, international operations, and internal controls.
Sam Eathington - Executive Vice President, Chief Technology and Digital Officer
Sam Eathington serves as Executive Vice President, Chief Technology and Digital Officer for Corteva. His background includes being a sixth-generation Illinois farmer. He holds a B.S. in agronomy, an M.S. in soybean breeding and genetics, and a Ph.D. in quantitative genetics and maize breeding, all from the University of Illinois, Urbana-Champaign.
Robert King - Executive Vice President, Crop Protection Business Unit
Robert King is the Executive Vice President, Crop Protection Business Unit at Corteva, a role he assumed in April 2022.
Judd O'Connor - Executive Vice President, Seed Business Unit
Judd O'Connor became Executive Vice President, Seed Business Unit for Corteva in December 2024. He has been with the company for over 25 years. Prior to his current role, he served as Corteva's Commercial President for North America since July 2022, and before that, as the Seed Commercial President for North America from August 2018. Before Corteva's spin-off from DowDuPont, Inc., Mr. O'Connor was a Vice President at DuPont Pioneer and played a key role in integration activities following the merger of DuPont and The Dow Chemical Company. His career at Corteva includes various leadership roles within the Pioneer brand sales organization.
AI Analysis | Feedback
Key Business Risks for Corteva (CTVA)
- Regulatory and Environmental Risks: Corteva operates within a highly regulated industry, necessitating continuous regulatory approvals for its seed and crop protection products to maintain market access. Changes in agricultural policies, government subsidies, and increasingly stringent environmental regulations, including those related to climate change, could significantly increase operating costs or restrict the company's ability to sell certain products globally.
- Competitive Pricing Pressure and Currency Fluctuations: The agricultural inputs sector is intensely competitive, particularly within the Crop Protection segment. This competition often leads to pricing pressures, especially evident in regions like Latin America, which can erode profit margins despite strong sales volumes. Additionally, Corteva's extensive international operations expose it to significant currency fluctuations, particularly involving the Brazilian Real, European Euro, and Canadian dollar, which can negatively impact reported revenue and earnings.
- Geopolitical Instability, Trade Policies, and Supply Chain Disruptions: As a global company, Corteva is exposed to risks arising from geopolitical instability, military conflicts, and changes in international trade policies, including tariffs and import/export restrictions. Complex global supply chains, coupled with reliance on various raw materials, also present vulnerabilities. Disruptions in these supply chains due to unforeseen events or shifts in raw material availability can lead to increased costs and affect the timely delivery of products.
AI Analysis | Feedback
AI Analysis | Feedback
Corteva (CTVA) operates in two primary segments: Seed and Crop Protection. The addressable markets for these main products and services are significant globally and across various regions.
Seed Segment
The global seed market was valued at approximately USD 61.68 billion in 2024 and is projected to reach around USD 112.49 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.80% during the forecast period. Other estimates place the global seed market size at USD 77 billion in 2025, growing to USD 105.16 billion by 2031 with a CAGR of 5.33%. Another report projects the global seed market size at USD 80.87 billion in 2026, anticipated to reach USD 121.67 billion by 2035, at a CAGR of 4.5%.
- North America: This region dominated the seed market, holding the largest revenue share of 33.6% in 2024. It is also projected to control 34.86% of the seed revenue in 2025 and experience the quickest expansion with a 6.21% CAGR through 2031.
- Asia-Pacific: This region dominates global seed consumption, accounting for over 43% of the global seed volume in 2023. It is also identified as the fastest-growing seed market and is expected to show the highest growth rate during 2022-2031.
Crop Protection Segment
The global crop protection chemicals market was valued at approximately USD 91.4 billion in 2023 and is estimated to reach USD 132.4 billion by 2032, with a CAGR of 4.2% between 2024 and 2032. Other projections indicate the market is expected to grow from USD 104.83 billion in 2025 to USD 137.49 billion by 2031, at a 4.62% CAGR. Another estimate shows the market growing from USD 88.71 billion in 2025 to USD 113.16 billion by 2031 at a 4.14% CAGR, while another values the market at USD 83.32 billion in 2025, projected to reach USD 106.26 billion by 2030, at a CAGR of 5.0%.
- Latin America/South America: This region held a dominant position in the crop protection chemicals market, accounting for a 32.0% value share in 2025. Specifically, South America commanded a 41.85% market share in 2025.
- Asia-Pacific: This region is the second-largest and fastest-growing regional market for crop protection chemicals, holding a 27.8% share in 2025. In 2021, the Asia-Pacific crop protection market grew to approximately $21 billion.
- Europe: Europe represents the third-largest regional market for crop protection chemicals, accounting for an 18.1% value share in 2025. The European market reached approximately $14 billion in 2021.
- North America: The North American crop protection chemicals market is projected to record a 4.2% CAGR between 2024 and 2032, with the U.S. dominating the region with a revenue of USD 36.5 billion in 2023.
AI Analysis | Feedback
Corteva (CTVA) is expected to drive future revenue growth over the next 2-3 years through several key initiatives and market dynamics:
- New Product Launches and Differentiated Technology: Corteva plans to introduce approximately 20 new products with over $200 million in revenue potential during 2024 and 2025, focusing on advanced seed technology with enhanced drought tolerance and pest resistance traits, as well as new crop protection products, including biologicals and insecticides. Demand for these new and differentiated technologies is a significant driver for both the Seed and Crop Protection segments. Additionally, the company is investing in research and development through initiatives like Corteva Catalyst to accelerate the development and commercialization of groundbreaking technologies, such as genome editing and hybrid wheat, which could deliver substantial yield advantages.
- Growth in the Biologicals Market: The agricultural biologicals market represents a key growth area for Corteva. The company achieved $420 million in biologicals revenue in 2023 and aims for $1 billion annually by the end of the decade. Acquisitions in the biologicals space contributed approximately $400 million in revenue in 2023, and the biologicals franchise is projected to add around $90 million of operating EBITDA with improved margins in 2024. Increased demand for new products, including biologicals, has already contributed to sales volume growth in the crop protection sector, particularly in regions like Brazil.
- Strategic Pricing Actions: Corteva's "price for value" strategy is a consistent driver of revenue growth, particularly in its Seed segment. The company has successfully implemented pricing gains across its portfolio, with average prices in the seed segment growing by 3% in 2024. This disciplined approach to pricing is expected to continue contributing to organic sales growth in the coming years.
- Volume Growth in Emerging Markets, especially Latin America and Asia Pacific: Corteva has experienced volume gains in Latin America and Asia Pacific, which have helped to offset declines in other regions. The expansion of planted areas, such as second-crop corn in Brazil, has directly influenced seed segment revenue growth. Strong volume gains in both Crop Protection and Seed, particularly in Brazil, were highlighted as drivers for the company's performance in Q4 2024.
- Expansion of Digital Agriculture Solutions: Corteva is investing in and expanding its digital agriculture platform, Granular, to provide farmers with data-driven insights. These digital services are poised to expand into new regions, supporting sustainable farming practices and optimizing product selection, yield, and profitability for farmers. The company's Corteva Catalyst initiative also includes "decision science" as one of its strategic verticals for identifying new opportunities.
AI Analysis | Feedback
Share Repurchases
- Corteva authorized a new $3 billion share repurchase program in November 2024, which is immediately effective and has no expiration date. This program is in addition to an existing $2 billion program announced in September 2022.
- The company executed annual share buybacks of approximately $1.009 billion in 2024 and $1.071 billion in 2025.
- Corteva returned over $1.5 billion to shareholders in fiscal 2025 through a combination of dividends and share repurchases. The company is targeting approximately $500 million in share repurchases for the first half of 2026.
Outbound Investments
- Corteva acquired the biologicals companies Stoller for $1.2 billion and Symborg, with the acquisitions closing in March 2023. These acquisitions were intended to strengthen Corteva's position in the rapidly expanding biologicals market.
- In 2025, Corteva invested in Latin American biological start-ups Puna Bio and Symbiomics through its venture arm, Catalyst.
- Corteva announced a plan in October 2025 to separate into two independent public companies in the second half of 2026, one for its Crop Protection business ("New Corteva") and one for its Seed business ("SpinCo"), aiming to accelerate value for shareholders.
Capital Expenditures
- Corteva's capital expenditures averaged $592.2 million annually from fiscal years 2021 to 2025.
- Reported capital expenditures were $573 million in 2021, $605 million in 2022, $595 million in 2023, $597 million in 2024, and $591 million in 2025.
- The company committed to restructuring activities in 2023 and 2024 to optimize its Crop Protection manufacturing and external partner network, with these activities expected to be substantially complete in 2026.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Corteva Stock In Shambles: Down 5.5% With 5-Day Losing Streak | 05/21/2026 | |
| Corteva Earnings Notes | 05/02/2026 | |
| CTVA Stock Surges 7.2% With A 7-day Winning Spree On JP Morgan PT Hike | 01/30/2026 | |
| How Low Can Corteva Stock Really Go? | 10/17/2025 | |
| Which Stock Wins: CF Industries or Corteva? | 10/14/2025 | |
| Should You Buy Corteva Stock? | 10/02/2025 | |
| ARTICLES | ||
| S&P 500 Stocks Trading At 52-Week High | 07/07/2026 | |
| Corteva Stock Plummets -5.5% With 5-Day Losing Streak | 05/21/2026 | |
| How Will Corteva Stock React To Its Upcoming Earnings? | 05/02/2026 | |
| Large Cap Stocks Trading At 52-Week High | 04/03/2026 | |
| Is CF Industries a Better Long-Term Bet Than Corteva? | 10/14/2025 |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 45.64 |
| Mkt Cap | 13.4 |
| Rev LTM | 9,918 |
| Op Inc LTM | 1,594 |
| FCF LTM | 789 |
| FCF 3Y Avg | 736 |
| CFO LTM | 1,755 |
| CFO 3Y Avg | 1,969 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 7.3% |
| Rev Chg 3Y Avg | -7.1% |
| Rev Chg Q | 12.7% |
| QoQ Delta Rev Chg LTM | 3.0% |
| Op Inc Chg LTM | 33.2% |
| Op Inc Chg 3Y Avg | -21.7% |
| Op Mgn LTM | 11.0% |
| Op Mgn 3Y Avg | 12.6% |
| QoQ Delta Op Mgn LTM | 0.8% |
| CFO/Rev LTM | 10.9% |
| CFO/Rev 3Y Avg | 13.7% |
| FCF/Rev LTM | 2.0% |
| FCF/Rev 3Y Avg | 4.2% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 13.4 |
| P/S | 0.9 |
| P/Op Inc | 7.8 |
| P/EBIT | 7.7 |
| P/E | 12.5 |
| P/CFO | 7.6 |
| Total Yield | 3.5% |
| Dividend Yield | 2.4% |
| FCF Yield 3Y Avg | 2.5% |
| D/E | 0.6 |
| Net D/E | 0.6 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 9.3% |
| 3M Rtn | -4.8% |
| 6M Rtn | -7.4% |
| 12M Rtn | -3.9% |
| 3Y Rtn | -7.8% |
| 1M Excs Rtn | 8.9% |
| 3M Excs Rtn | -11.1% |
| 6M Excs Rtn | -15.6% |
| 12M Excs Rtn | -22.3% |
| 3Y Excs Rtn | -67.5% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Seed | 9,898 | 9,545 | 9,472 | 8,979 | 8,402 |
| Crop Protection | 7,503 | 7,363 | 7,754 | 8,476 | 7,253 |
| Total | 17,401 | 16,908 | 17,226 | 17,455 | 15,655 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Seed | 21,246 | 22,732 | 22,952 | 23,270 | 23,751 |
| Crop Protection | 14,241 | 15,004 | 14,097 | 12,428 | 13,099 |
| Corporate assets | 5,338 | 5,260 | 5,569 | 6,646 | 5,799 |
| Total | 40,825 | 42,996 | 42,618 | 42,344 | 42,649 |
Price Behavior
| Market Price | $88.53 | |
| Market Cap ($ Bil) | 59.5 | |
| First Trading Date | 05/24/2019 | |
| Distance from 52W High | 0.0% | |
| 50 Days | 200 Days | |
| DMA Price | $81.17 | $74.13 |
| DMA Trend | up | indeterminate |
| Distance from DMA | 9.1% | 19.4% |
| 3M | 1YR | |
| Volatility | 22.3% | 23.7% |
| Downside Capture | -8.31 | 4.54 |
| Upside Capture | 44.57 | 26.12 |
| Correlation (SPY) | 9.9% | 11.6% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.17 | 0.26 | 0.06 | 0.20 | 0.25 | 0.59 |
| Up Beta | 0.14 | -0.06 | -0.26 | -0.28 | 0.02 | 0.52 |
| Down Beta | 0.48 | 0.12 | 0.20 | 0.49 | 0.50 | 0.76 |
| Up Capture | 58% | 50% | 15% | 45% | 21% | 27% |
| Bmk +ve Days | 11 | 24 | 40 | 67 | 140 | 429 |
| Stock +ve Days | 13 | 22 | 32 | 72 | 139 | 391 |
| Down Capture | -35% | 32% | 23% | 3% | 22% | 77% |
| Bmk -ve Days | 10 | 17 | 23 | 58 | 112 | 321 |
| Stock -ve Days | 8 | 19 | 31 | 53 | 112 | 355 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CTVA | |
|---|---|---|---|---|
| CTVA | 22.5% | 23.7% | 0.80 | - |
| Sector ETF (XLB) | 13.8% | 17.6% | 0.58 | 46.7% |
| Equity (SPY) | 20.0% | 12.6% | 1.16 | 11.3% |
| Gold (GLD) | 21.2% | 28.1% | 0.67 | 11.6% |
| Commodities (DBC) | 33.0% | 19.1% | 1.36 | 15.2% |
| Real Estate (VNQ) | 13.9% | 14.0% | 0.70 | 18.0% |
| Bitcoin (BTCUSD) | -43.6% | 42.9% | -1.21 | 7.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CTVA | |
|---|---|---|---|---|
| CTVA | 17.0% | 26.9% | 0.58 | - |
| Sector ETF (XLB) | 6.3% | 19.0% | 0.22 | 57.5% |
| Equity (SPY) | 12.8% | 17.1% | 0.58 | 40.0% |
| Gold (GLD) | 17.3% | 18.4% | 0.76 | 11.2% |
| Commodities (DBC) | 9.3% | 19.5% | 0.37 | 25.3% |
| Real Estate (VNQ) | 2.7% | 18.9% | 0.04 | 36.6% |
| Bitcoin (BTCUSD) | 15.2% | 53.5% | 0.46 | 15.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CTVA | |
|---|---|---|---|---|
| CTVA | 12.8% | 32.5% | 0.59 | - |
| Sector ETF (XLB) | 9.9% | 20.6% | 0.43 | 63.6% |
| Equity (SPY) | 15.1% | 17.9% | 0.72 | 51.4% |
| Gold (GLD) | 11.5% | 16.1% | 0.58 | 5.7% |
| Commodities (DBC) | 7.1% | 17.9% | 0.31 | 29.7% |
| Real Estate (VNQ) | 5.0% | 20.7% | 0.20 | 47.3% |
| Bitcoin (BTCUSD) | 58.5% | 66.2% | 0.99 | 19.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 6/29/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 5/5/2026 | -2.5% | -1.6% | -7.5% |
| 2/3/2026 | 0.1% | -1.1% | 2.3% |
| 11/4/2025 | 1.9% | 5.2% | 5.9% |
| 8/6/2025 | -0.2% | 1.6% | 1.8% |
| 5/7/2025 | 7.0% | 8.2% | 14.9% |
| 2/5/2025 | -2.3% | -2.8% | -4.9% |
| 11/6/2024 | -5.0% | -6.6% | -3.4% |
| 7/31/2024 | -5.5% | -9.5% | 1.6% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 12 | 12 | 15 |
| # Negative | 12 | 12 | 9 |
| Median Positive | 4.2% | 6.9% | 5.9% |
| Median Negative | -4.0% | -4.7% | -6.5% |
| Max Positive | 18.9% | 18.9% | 18.3% |
| Max Negative | -11.0% | -9.5% | -7.9% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 5/5/2026 | -2.5% | -1.6% | -7.5% |
| 2/3/2026 | 0.1% | -1.1% | 2.3% |
| 11/4/2025 | 1.9% | 5.2% | 5.9% |
| 8/6/2025 | -0.2% | 1.6% | 1.8% |
| 5/7/2025 | 7.0% | 8.2% | 14.9% |
| 2/5/2025 | -2.3% | -2.8% | -4.9% |
| 11/6/2024 | -5.0% | -6.6% | -3.4% |
| 7/31/2024 | -5.5% | -9.5% | 1.6% |
| 5/1/2024 | 5.7% | 5.4% | 3.8% |
| 1/31/2024 | 18.9% | 18.9% | 18.3% |
| 11/8/2023 | -8.5% | -3.9% | -6.8% |
| 8/3/2023 | 0.6% | -6.2% | -7.9% |
| 5/3/2023 | -5.2% | -4.0% | -6.5% |
| 2/1/2023 | -3.8% | -4.0% | -1.0% |
| 11/3/2022 | -2.4% | 0.6% | -3.5% |
| 8/4/2022 | 4.9% | 9.4% | 11.2% |
| 5/4/2022 | -1.9% | -9.4% | 5.1% |
| 2/2/2022 | 0.8% | 7.1% | 7.3% |
| 11/3/2021 | 5.8% | 6.7% | 3.0% |
| 8/5/2021 | 8.0% | 11.5% | 8.7% |
| 5/4/2021 | -4.2% | -5.4% | -7.4% |
| 2/3/2021 | 1.9% | 2.8% | 7.4% |
| 11/4/2020 | 3.5% | 11.7% | 18.3% |
| 8/5/2020 | -11.0% | -7.7% | 3.5% |
| SUMMARY STATS | |||
| # Positive | 12 | 12 | 15 |
| # Negative | 12 | 12 | 9 |
| Median Positive | 4.2% | 6.9% | 5.9% |
| Median Negative | -4.0% | -4.7% | -6.5% |
| Max Positive | 18.9% | 18.9% | 18.3% |
| Max Negative | -11.0% | -9.5% | -7.9% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 02/12/2026 | 10-K |
| 09/30/2025 | 11/05/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/08/2025 | 10-Q |
| 12/31/2024 | 02/14/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/02/2024 | 10-Q |
| 12/31/2023 | 02/08/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/04/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/09/2023 | 10-K |
| 09/30/2022 | 11/04/2022 | 10-Q |
| 06/30/2022 | 08/05/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 02/12/2026 | 10-K |
| 09/30/2025 | 11/05/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/08/2025 | 10-Q |
| 12/31/2024 | 02/14/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/02/2024 | 10-Q |
| 12/31/2023 | 02/08/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/04/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/09/2023 | 10-K |
| 09/30/2022 | 11/04/2022 | 10-Q |
| 06/30/2022 | 08/05/2022 | 10-Q |
| 03/31/2022 | 05/05/2022 | 10-Q |
| 12/31/2021 | 02/10/2022 | 10-K |
| 09/30/2021 | 11/04/2021 | 10-Q |
| 06/30/2021 | 08/06/2021 | 10-Q |
| 03/31/2021 | 05/05/2021 | 10-Q |
| 12/31/2020 | 02/11/2021 | 10-K |
| 09/30/2020 | 11/05/2020 | 10-Q |
| 06/30/2020 | 08/06/2020 | 10-Q |
| 03/31/2020 | 05/07/2020 | 10-Q |
| 12/31/2019 | 02/14/2020 | 10-K |
| 09/30/2019 | 10/31/2019 | 10-Q |
| 06/30/2019 | 08/06/2019 | 10-Q |
Recent Forward Guidance
Updated 7/8/2026Latest: Q1 2026 Earnings Reported 5/5/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Operating EBITDA | 4.00 Bil | 4.10 Bil | 4.20 Bil | 0 | Affirmed | Guidance: 4.10 Bil for 2026 | |
| 2026 Operating EPS | 3.45 | 3.58 | 3.7 | 0 | Affirmed | Guidance: 3.58 for 2026 | |
| 2026 Share Repurchases | 500.00 Mil | ||||||
| 2026 Separation Costs | 350.00 Mil | ||||||
| 2026 Restructuring Charges | 80.00 Mil | 85.00 Mil | 90.00 Mil | ||||
Prior: Q4 2025 Earnings Reported 2/3/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Operating EBITDA | 4.00 Bil | 4.10 Bil | 4.20 Bil | 0 | Affirmed | Guidance: 4.10 Bil for 2026 | |
| 2026 Operating EPS | 3.45 | 3.58 | 3.7 | ||||
Q3 2025 Earnings Reported 11/4/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2025 Revenue | 17.70 Bil | 17.80 Bil | 17.90 Bil | 0.6% | Raised | Guidance: 17.70 Bil for 2025 | |
| 2025 Operating EBITDA | 3.80 Bil | 3.85 Bil | 3.90 Bil | 1.3% | Raised | Guidance: 3.80 Bil for 2025 | |
| 2025 Operating EPS | 3.25 | 3.3 | 3.35 | 6.5% | Raised | Guidance: 3.1 for 2025 | |
| 2025 Share Repurchases | 1.00 Bil | 0.0% | Affirmed | Guidance: 1.00 Bil for 2025 | |||
| 2026 Operating EBITDA | 4.10 Bil | ||||||
Insider Activity
Updated 5/4/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Titus, Brian | See Remarks | Direct | Sell | 2242026 | 76.55 | 8,311 | 636,200 | 619,282 | Form |
| 2 | King, Robert D | EVP, Crop Protection Business | Direct | Sell | 9022025 | 74.20 | 37,280 | 2,765,993 | 3,655,020 | Form |
| 3 | Fuerer, Cornel B | See Remarks | Direct | Sell | 5152025 | 68.06 | 55,242 | 3,759,771 | 6,917,708 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Titus, Brian | See Remarks | Direct | Sell | 2242026 | 76.55 | 8,311 | 636,200 | 619,282 | Form |
| 2 | King, Robert D | EVP, Crop Protection Business | Direct | Sell | 9022025 | 74.20 | 37,280 | 2,765,993 | 3,655,020 | Form |
| 3 | Fuerer, Cornel B | See Remarks | Direct | Sell | 5152025 | 68.06 | 55,242 | 3,759,771 | 6,917,708 | Form |
Investor Activity (13F)
Updated Jul 23, 2026Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.
| Active Manager | Value | % of Portfolio | Total Positions | QoQ | Filing |
|---|---|---|---|---|---|
| Anomaly Capital Management, LP | $88.4 Mil | 5.4% | 21 | TRIM -64.0% | 13F |
| TSP Capital Management Group, LLC | $17.7 Mil | 4.3% | 45 | Hold | 13F |
| Stanley Capital Management, LLC | $21.9 Mil | 3.7% | 40 | Hold | 13F |
| Albar Capital Partners LLP | $13.1 Mil | 2.1% | 36 | TRIM -66.3% | 13F |
| Independent Franchise Partners LLP | $99.5 Mil | 0.7% | 26 | TRIM -88.7% | 13F |
| Active Manager |
|---|
| Active Manager | Value | % of Portfolio | Total Positions | QoQ | As Of | Filing |
|---|---|---|---|---|---|---|
| Drummond Knight Asset Management Pty Ltd | $25.7 Mil | 7.2% | 11 | Exited | Dec 31, 2025 | 13F |
| St. James Investment Company, LLC | $15.1 Mil | 2.4% | 30 | Exited | Dec 31, 2025 | 13F |
| Independent Franchise Partners LLP | $99.5 Mil | 0.7% | 26 | TRIM -88.7% | Mar 31, 2026 | 13F |
| Albar Capital Partners LLP | $13.1 Mil | 2.1% | 36 | TRIM -66.3% | Mar 31, 2026 | 13F |
| Anomaly Capital Management, LP | $88.4 Mil | 5.4% | 21 | TRIM -64.0% | Mar 31, 2026 | 13F |
| Active Manager | Value | % of Portfolio | Total Positions | QoQ | Filing |
|---|---|---|---|---|---|
| Independent Franchise Partners LLP | $99.5 Mil | 0.7% | 26 | TRIM -88.7% | 13F |
| Anomaly Capital Management, LP | $88.4 Mil | 5.4% | 21 | TRIM -64.0% | 13F |
| Stanley Capital Management, LLC | $21.9 Mil | 3.7% | 40 | Hold | 13F |
| TSP Capital Management Group, LLC | $17.7 Mil | 4.3% | 45 | Hold | 13F |
| Albar Capital Partners LLP | $13.1 Mil | 2.1% | 36 | TRIM -66.3% | 13F |
Corteva — Investor Video Playlist
Industry Resources
| Materials Resources |
| Chemical & Engineering News (C&EN) |
| Mining.com |
| Plastics News |
| Fertilizers & Agricultural Chemicals Resources |
| World Fertilizer |
| Fertilizer Daily |
| Argus Media - Fertilizer |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.